Broadfin Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Broadfin Capital’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell
2018 Q4	$2.83M	Sell
2018 Q3	$3.32M	Buy
2016 Q1	–	Sell
2015 Q4	$4.27M	Hold
2015 Q3	$4.21M	Hold
2015 Q2	$8.43M	Buy